Mirae Asset Capital Life Science

Exciting news from our portfolio company Accent Therapeutics, Inc. on receiving IND clearance for ATX-559, a first-in-class oral #DHX9 inhibitor. ATX-559 Phase 1/2 trial (NCT06625515) will focus on patients with BRCA1/2-deficient breast cancer and MSI-H and/or dMMR cancers to evaluate safety, tolerability, PK/PD, and preliminary efficacy of ATX-559. Press release: https://lnkd.in/gXQQVKXV Mirae Asset Capital Life Science and the affiliates are pleased to support Shakti Narayan and the Accent team in making this breakthrough in developing and advancing a first-in-class DHX9 inhibitor and pushing the boundaries in #PrecisionOncology. Naveen Krishnan David Paik Daniel Kwon Ray Hyo Won Ahn Hansoo Kim Mirae Asset Capital #DHX9 #breastcancer #MSIhigh #dMMR #KIF18A #Oncology #AccentTherapeutics #biotech

Excited to work with you, the other investors, Ken, and the Candid team to bring therapies to patients!

We are proud to invest alongside this top-tier group of investors, humbled to see the over $370M of capital that has come into the company, and excited to work this stellar management team led by Ken Song to advance bispecific T-cell engager antibodies as treatments for autoimmune diseases as part of Candid Therapeutics! Naveen Krishnan, David T. Paik, #MiraeAsset #MiraeAssetCapitalLifeScience

We are thrilled to announce our second investment in Vignette Bio after sourcing EMB-06 (BCMA x CD3 T-cell engager) from EpimAb Biotherapeutics, Inc. (Mirae Asset portfolio company), and bringing it to Foresite Capital. We look forward to working with Foresite Capital, Qiming Venture Partners, Qiming Venture Partners USA, and Samsara Biocapital to try to revolutionize the treatment of autoimmune disease with bispecific T-cell engagers. We will continue to look for valuable assets globally across our core sectors utilizing our strong global network, please reach out to us at lifesci@miraeasset.com if you are interested in discussing further. Please stay tuned for more exciting announcements in the coming weeks! Naveen Krishnan, David T. Paik, #MiraeAssetCapitalLifeScience #MiraeAssetCapital, #MiraeAsset, #VignetteBio, #ForesiteCapital, #Qiming, #Samsara, #Epimab, #bispecifics, #TCEs, #autoimmunedisease, #immunereset https://lnkd.in/dTyCQxfb

Please note our Associate/Sr. Associate job posting is back to being active, if you are interested please apply below! https://lnkd.in/ePEEzFa8 #miraeasset #lifescience #biotech Naveen Krishnan David T. Paik

We are hiring an Associate/Sr. Associate to join our investment team in Boston! If you are passionate about life science and interested in venture capital please apply! Please check out more info below and on our website (www.lifesci.miraeasset.com). #lifescience #venturecapital #miraeasset Naveen Krishnan David T. Paik Mirae Asset Global Investments https://lnkd.in/ePEEzFa8

We congratulate Global X ETFs for celebrating the 15th anniversary of their first product listing and ringing the NYSE closing bell on Thursday! https://lnkd.in/gsuAJbap

We thank Brian Gormley for highlighting Mirae Asset Capital Life Science's launch and vision in The Wall Street Journal. Read here: https://lnkd.in/eWRFbRZZ Mirae Asset Capital Life Science Naveen Krishnan David T. Paik #LifeScience #MiraeAsset #VentureCapital #Therapeutics

Mirae Asset Capital Life Science is thrilled to lead the $75M series C financing round for Accent Therapeutics, Inc. and to work closely with its stellar team led by Shakti Narayan and Robert Copeland to enable development of novel and high-impact therapies for oncology patients. Learn more: https://lnkd.in/eNPeBAB8 Accent Therapeutics, Inc. Mirae Asset Capital Life Science Naveen Krishnan Mirae Asset Capital Daniel KWON Hansoo Kim Mirae Asset Venture Investment Ray Hyo Won Ahn, PharmD #Biotech #Therapeutics #PrecisionOncology #MiraeAsset #VentureCapital #LifeScience #DHX9 #KIF18A

We are excited to announce the launch of our first fund! Please read below: https://lnkd.in/gRkxYiRv We extend our gratitude to our affiliates for their support and belief in us and our mission. Naveen Krishnan David T. Paik Hansoo Kim Mirae Asset Capital Life Science Mirae Asset Global Investments Mirae Asset Capital #biotech #venturecapital #investment #therapeutics #MiraeAsset #lifescience